المؤلفون: Fan, Yun, Drilon, Alexander, Chiu, Chao-Hua, Loong, Herbert H.F., Siena, Salvatore, Krzakowski, Maciej, Dziadziuszko, Rafal, Zeuner, Harald, Xue, Cloris, Krebs, Matthew G.

المصدر: Fan , Y , Drilon , A , Chiu , C-H , Loong , H H F , Siena , S , Krzakowski , M , Dziadziuszko , R , Zeuner , H , Xue , C & Krebs , M G 2024 , ' Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer ' , Clinical Lung Cancer , vol. 25 , no. 2 , pp. e81-e86.e4 . https://doi.org/10.1016/j.cllc.2023.12.001Test

مصطلحات موضوعية: First-line treatment, Intracranial efficacy, NSCLC, Tyrosine kinase inhibitor

العلاقة: https://research.manchester.ac.uk/en/publications/8dffb931-cfdc-476a-9ab7-3e5949c965fdTest

الإتاحة: https://doi.org/10.1016/j.cllc.2023.12.001Test
https://research.manchester.ac.uk/en/publications/8dffb931-cfdc-476a-9ab7-3e5949c965fdTest
http://www.scopus.com/inward/record.url?scp=85183574357&partnerID=8YFLogxKTest
https://www.mendeley.com/catalogue/03f63f5b-0aca-305a-993b-08e1608c2f6bTest/
https://www.sciencedirect.com/science/article/pii/S1525730423002589Test

المؤلفون: Alexander Drilon, MD, Chao-Hua Chiu, MD, Yun Fan, MD, Byoung Chul Cho, MD, PhD, Shun Lu, MD, PhD, Myung-Ju Ahn, MD, PhD, Matthew G. Krebs, MD, PhD, Stephen V. Liu, MD, Thomas John, MD, Gregory A. Otterson, MD, Daniel S.W. Tan, MD, Tejas Patil, MD, Rafal Dziadziuszko, MD, PhD, Erminia Massarelli, MD, PhD, Takashi Seto, MD, Robert C. Doebele, MD, PhD, Bethany Pitcher, MSc, Nino Kurtsikidze, MD, Sebastian Heinzmann, PhD, Salvatore Siena, MD

المصدر: JTO Clinical and Research Reports, Vol 3, Iss 6, Pp 100332- (2022)

مصطلحات موضوعية: Entrectinib, Intracranial efficacy, NSCLC, ROS1 fusions, Treatment post-crizotinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S266636432200056XTest; https://doaj.org/toc/2666-3643Test

الوصول الحر: https://doaj.org/article/46b674c9f39d4db4b8d61e682c4faee9Test

المؤلفون: Aaron C. Tan, Drexell H. Boggs, Eudocia Q. Lee, Michelle M. Kim, Minesh P. Mehta, Mustafa Khasraw

المصدر: Frontiers in Oncology, Vol 11 (2022)

مصطلحات موضوعية: brain metastases, trial eligibility, intracranial efficacy, novel therapeutic agents, CNS metastases, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.780379/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/9e7528317dd84f12b6db5692ca468206Test

المؤلفون: Drilon, Alexander, Chiu, Chao-Hua, Fan, Yun, Cho, Byoung Chul, Lu, Shun, Ahn, Myung-Ju, Krebs, Matthew G, Liu, Stephen V, John, Thomas, Otterson, Gregory A, Tan, Daniel S W, Patil, Tejas, Dziadziuszko, Rafal, Massarelli, Erminia, Seto, Takashi, Doebele, Robert C, Pitcher, Bethany, Kurtsikidze, Nino, Heinzmann, Sebastian, Siena, Salvatore

المساهمون: A. Drilon, C. Chiu, Y. Fan, B.C. Cho, S. Lu, M. Ahn, M.G. Kreb, S.V. Liu, T. John, G.A. Otterson, D.S.W. Tan, T. Patil, R. Dziadziuszko, E. Massarelli, T. Seto, R.C. Doebele, B. Pitcher, N. Kurtsikidze, S. Heinzmann, S. Siena

مصطلحات موضوعية: Entrectinib, Intracranial efficacy, NSCLC, ROS1 fusion, Treatment post-crizotinib, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35663414; volume:3; issue:6; firstpage:1; lastpage:13; numberofpages:13; journal:JTO CLINICAL AND RESEARCH REPORTS; http://hdl.handle.net/2434/930503Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85131050255

الإتاحة: https://doi.org/10.1016/j.jtocrr.2022.100332Test
http://hdl.handle.net/2434/930503Test

المؤلفون: AC Tan, DH Boggs, EQ Lee, MM Kim, MP Mehta, M Khasraw

مصطلحات موضوعية: Oncology and carcinogenesis not elsewhere classified, brain metastases, trial eligibility, intracranial efficacy, novel therapeutic agents, CNS metastases, 3211 Oncology and carcinogenesis

العلاقة: http://hdl.handle.net/10536/DRO/DU:30162293Test; https://figshare.com/articles/journal_contribution/Clinical_Trial_Eligibility_Criteria_and_Recently_Approved_Cancer_Therapies_for_Patients_With_Brain_Metastases/20622420Test

الإتاحة: http://hdl.handle.net/10536/DRO/DU:30162293Test
https://figshare.com/articles/journal_contribution/Clinical_Trial_Eligibility_Criteria_and_Recently_Approved_Cancer_Therapies_for_Patients_With_Brain_Metastases/20622420Test

المؤلفون: Aaron C. Tan (11893265), Drexell H. Boggs (11893268), Eudocia Q. Lee (10748781), Michelle M. Kim (11893271), Minesh P. Mehta (9677255), Mustafa Khasraw (6335354)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, brain metastases, trial eligibility, intracranial efficacy, novel therapeutic agents, CNS metastases

العلاقة: https://figshare.com/articles/dataset/Table_1_Clinical_Trial_Eligibility_Criteria_and_Recently_Approved_Cancer_Therapies_for_Patients_With_Brain_Metastases_docx/17712773Test

الإتاحة: https://doi.org/10.3389/fonc.2021.780379.s001Test

مصطلحات الفهرس: brain metastases, trial eligibility, intracranial efficacy, novel therapeutic agents, CNS metastases, Journal Article

URL: http://hdl.handle.net/10536/DRO/DU:30162293Test
http://doi.org/10.3389/fonc.2021.780379Test
http://elements.deakin.edu.au/viewobject.html?id=293390&cid=1Test
issn: 2234-943X
http://doi.org/10.3389/fonc.2021.780379Test
http://elements.deakin.edu.au/viewobject.html?id=293390&cid=1Test
Frontiers in Oncology